Human ‘knockouts’ of CSF3 display severe congenital neutropenia
Ebtissal Khouj, Dana Marafi, Bayan Aljamal, Anwar Hajiya, Reem M. Elshafie, Mais O. Hashem, Firdous Abdulwahab, Amal Jaafar, Tarfa Alshidi, Ashraf H. Aboelanine, Ali Awaji, Fowzan S. Alkuraya- Hematology
Summary
Colony‐stimulating factor 3 (CSF3) is a key factor in neutrophil production and function, and recombinant forms have been used clinically for decades to treat congenital and acquired neutropenia. Although biallelic inactivation of its receptor CSF3R is a well‐established cause of severe congenital neutropenia (SCN), no corresponding Mendelian disease has been ascribed to date to CSF3. Here, we describe three patients from two families each segregating a different biallelic inactivating variant in CSF3 with SCN. Complete deficiency of CSF3 as a result of nonsense‐mediated decay (NMD) could be demonstrated on RT‐PCR using skin fibroblasts‐derived RNA. The phenotype observed in this cohort mirrors that documented in mouse and zebrafish models of CSF3 deficiency. Our results suggest that CSF3 deficiency in humans causes a novel autosomal recessive form of SCN.